Current issue
Archive
Online first
About the Journal
Editorial Office
Editorial Board
Publisher
Editorial Policies
Ethical standards and procedures
Abstracting and indexing
Reviewers
Honorary Reviewers
Subscription
Contact
Most read articles
Instructions for authors
Article processing charge (APC)
Books and Events
Books
Events
ORIGINAL PAPER
Association of ANO6 gene polymorphism and expression with ankylosing spondylitis in a Chinese Han population
1
Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2
Shenzhen Longhua District Central Hospital, Shenzhen, China
These authors had equal contribution to this work
Submission date: 2025-04-07
Final revision date: 2025-10-07
Acceptance date: 2025-10-22
Publication date: 2026-06-29
Corresponding author
Reumatologia 2026;64(3):192-199
KEYWORDS
TOPICS
ABSTRACT
Introduction:
This study aimed to explore the genetic polymorphisms and aberrant expression of Anoctamin 6 (ANO6) in Ankylosing Spondylitis (AS) patients to understand its role in AS pathogenesis.
Material and methods:
Genetic sequencing was performed to identify disease-associated single nucleotide polymorphisms (SNPs) within the exonic and transcriptional regulatory regions of ANO6 in 417 AS patients and 541 healthy controls (HCs). Linkage disequilibrium and haplotype analyses were conducted to assess the association of the candidate SNPs with disease susceptibility. A cohort of 2,144 AS patients was stratified based on the presence or absence of risk-associated haplotypes and clinical phenotypes were compared between the two groups. Reverse transcription-polymerase chain reaction (RT-PCR) was employed to quantify mRNA expression levels in peripheral blood mononuclear cells (PBMCs) from 40 AS patients and 32 HCs. Immunohistochemistry (IHC) was utilized to evaluate ANO6 protein expression in tendon tissues from 9 AS patients and 5 control subjects.
Results:
Five SNP loci (rs79662606, rs76186361, rs17095830, rs80224086, and rs75712006) exhibited significant associations with AS susceptibility, with strong linkage disequilibrium observed between pairwise loci. Haplotype analysis revealed a higher prevalence of GTGCG, ATGTA, and ACGTA haplotypes in AS patients (p < 0.001). No significant differences in clinical phenotypes were observed between AS patients with or without risk-associated haplotypes. mRNA expression in PBMCs was significantly lower in AS patients (0.49 ± 0.21) compared to HCs (0.86 ± 0.38) (p < 0.001). Conversely, ANO6 protein expression was significantly elevated in tendon tissues of AS patients, with an average Histoscore of 182.22 ± 30.732 compared to 62.00 ± 35.637 in controls (p = 0.001).
Conclusions:
ANO6 may represent a novel AS susceptibility gene, with GTGCG, ATGTA, and ACGTA as risk-associated haplotypes. Dysregulated ANO6 expression in PBMCs and tendon tissues suggests its potential role in AS pathogenesis.
This study aimed to explore the genetic polymorphisms and aberrant expression of Anoctamin 6 (ANO6) in Ankylosing Spondylitis (AS) patients to understand its role in AS pathogenesis.
Material and methods:
Genetic sequencing was performed to identify disease-associated single nucleotide polymorphisms (SNPs) within the exonic and transcriptional regulatory regions of ANO6 in 417 AS patients and 541 healthy controls (HCs). Linkage disequilibrium and haplotype analyses were conducted to assess the association of the candidate SNPs with disease susceptibility. A cohort of 2,144 AS patients was stratified based on the presence or absence of risk-associated haplotypes and clinical phenotypes were compared between the two groups. Reverse transcription-polymerase chain reaction (RT-PCR) was employed to quantify mRNA expression levels in peripheral blood mononuclear cells (PBMCs) from 40 AS patients and 32 HCs. Immunohistochemistry (IHC) was utilized to evaluate ANO6 protein expression in tendon tissues from 9 AS patients and 5 control subjects.
Results:
Five SNP loci (rs79662606, rs76186361, rs17095830, rs80224086, and rs75712006) exhibited significant associations with AS susceptibility, with strong linkage disequilibrium observed between pairwise loci. Haplotype analysis revealed a higher prevalence of GTGCG, ATGTA, and ACGTA haplotypes in AS patients (p < 0.001). No significant differences in clinical phenotypes were observed between AS patients with or without risk-associated haplotypes. mRNA expression in PBMCs was significantly lower in AS patients (0.49 ± 0.21) compared to HCs (0.86 ± 0.38) (p < 0.001). Conversely, ANO6 protein expression was significantly elevated in tendon tissues of AS patients, with an average Histoscore of 182.22 ± 30.732 compared to 62.00 ± 35.637 in controls (p = 0.001).
Conclusions:
ANO6 may represent a novel AS susceptibility gene, with GTGCG, ATGTA, and ACGTA as risk-associated haplotypes. Dysregulated ANO6 expression in PBMCs and tendon tissues suggests its potential role in AS pathogenesis.
REFERENCES (29)
1.
Ng SC, Liao Z, Yu DT, et al. Epidemiology of spondyloarthritis in the People’s Republic of China: review of the literature and commentary. Semin Arthritis Rheum 2007; 37: 39–47, DOI: 10.1016/j.semarthrit.2007.01.003.
2.
Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum 1993; 22: 319–334, DOI: 10.1016/s0049-0172(05)80011-3.
3.
Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997; 40: 1823–1828, DOI: 10.1002/art.1780401015.
4.
Fussell H, Nesbeth D, Lenart I, et al. Novel detection of in vivo HLA-B27 conformations correlates with ankylosing spondylitis association. Arthritis Rheum 2008; 58: 3419–3424, DOI: 10.1002/art.23990.
5.
Zeng QY, Chen R, Darmawan J, et al. Rheumatic diseases in China. Arthritis Res Ther 2008; 10: R17, DOI: 10.1186/ar2368.
6.
Gran JT, Husby G, Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway. Ann Rheum Dis 1985; 44: 359–367, DOI: 10.1136/ard.44.6.359.
7.
Lin Z, Bei JX, Shen M, et al. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet 2011; 44: 73–77, DOI: 10.1038/ng.1005.
8.
Urano T, Narusawa K, Shiraki M, et al. Single-nucleotide polymorphism in the hyaluronan and proteoglycan link protein 1 (HAPLN1) gene is associated with spinal osteophyte formation and disc degeneration in Japanese women. Eur Spine J 2011; 20: 572–577, DOI: 10.1007/s00586-010-1598-0.
9.
Glantschnig H, Hampton RA, Lu P, et al. Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo. J Biol Chem 2010; 285: 40135–40147, DOI: 10.1074/jbc.M110.166892.
10.
Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010; 468: 834–838, DOI: 10.1038/nature09583.
11.
Hartzell HC, Yu K, Xiao Q, et al. Anoctamin/TMEM16 family members are Ca2+-activated Cl– channels. J Physiol 2009; 587: 2127–2139, DOI: 10.1113/jphysiol.2008.163709.
12.
Lian Z, Luo W, Liu J, et al. Analysis of ANO6, HAPLN1, and EDIL3 polymorphisms in patients with ankylosing spondylitis in a Chinese Han population: A case-control study. Genet Test Mol Biomarkers 2024; 28: 385–392, DOI: 10.1089/gtmb. 2023.0569.
13.
Wei JC, Hsu YW, Hung KS, et al. Association study of polymorphisms rs4552569 and rs17095830 and the risk of ankylosing spondylitis in a Taiwanese population. PLoS One 2013; 8: e52801, DOI: 10.1371/journal.pone.0052801.
14.
Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361–368, DOI: 10.1002/art.1780270401.
15.
Salazar LA, Hirata MH, Cavalli SA, et al. Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem 1998; 44: 1748–1750.
16.
Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45, DOI: 10.1093/nar/29.9.e45.
17.
Yang XH, Wu QL, Yu XB, et al. Nestin expression in different tumours and its relevance to malignant grade. J Clin Pathol 2008; 61: 467–473, DOI: 10.1136/jcp.2007.047605.
18.
Willer CJ, Scott LJ, Bonnycastle LL, et al. Tag SNP selection for Finnish individuals based on the CEPH Utah HapMap database. Genet Epidemiol 2006; 30: 180–190, DOI: 10.1002/gepi.20131.
19.
Australo-Anglo-American Spondyloarthritis Consortium (TASC); Reveille JD, Sims AM, Danoy P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010; 42: 123–127, DOI: 10.1038/ng.513.
20.
Mauro D, Thomas R, Guggino G, et al. Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol 2021; 17: 387–404, DOI: 10.1038/s41584-021-00625-y.
21.
Caputo A, Caci E, Ferrera L, et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 2008; 322: 590–594, DOI: 10.1126/science.1163518.
22.
Galietta LJ, Pagesy P, Folli C, et al. IL-4 is a potent modulator of ion transport in the human bronchial epithelium in vitro. J Immunol 2002; 168: 839–845, DOI: 10.4049/jimmunol. 168.2.839.
23.
Szteyn K, Schmid E, Nurbaeva MK, et al. Expression and functional significance of the Ca(2+)-activated Cl(–) channel ANO6 in dendritic cells. Cell Physiol Biochem 2012; 30: 1319–1332, DOI: 10.1159/000343321.
24.
Ousingsawat J, Wanitchakool P, Kmit A, et al. Anoctamin 6 mediates effects essential for innate immunity downstream of P2X7 receptors in macrophages. Nat Commun 2015; 6: 6245, DOI: 10.1038/ncomms7245.
25.
Ehlen HW, Chinenkova M, Moser M, et al. Inactivation of anoctamin-6/Tmem16f, a regulator of phosphatidylserine scrambling in osteoblasts, leads to decreased mineral deposition in skeletal tissues. J Bone Miner Res 2013; 28: 246–259, DOI: 10.1002/jbmr.1751.
26.
Layh-Schmitt G, Lu S, Navid F, et al. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors. Clin Rheumatol 2017; 36: 143–154, DOI: 10.1007/s10067-016-3469-5.
27.
Benjamin M, McGonagle D. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 2001; 199: 503–526, DOI: 10.1046/j.1469-7580.2001.19950503.x.
28.
François RJ, Neure L, Sieper J, Braun J. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 2006; 65: 713–720, DOI: 10.1136/ard.2005.037465.
29.
Appel H, Kuhne M, Spiekermann S, et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006; 54: 2845–2851, DOI: 10.1002/art.22060.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
